| Literature DB >> 20571365 |
Adam Stewart1, Keith Wong, Jonathan Cachat, Marco Elegante, Tom Gilder, Sopan Mohnot, Nadine Wu, Anna Minasyan, Pentti Tuohimaa, Allan V Kalueff.
Abstract
Vitamin D is becoming increasingly recognized as a nontraditional drug target for different brain pathologies. Although widely known for their role in calcium metabolism, vitamin D and its receptor have been linked to several brain disorders, including cognitive decline, epilepsy, affective disorders, and schizophrenia. Here we discuss mounting evidence, and parallel recent clinical and animal behavioral, genetic and pharmacological data to emphasize the emerging role of the neurosteroid vitamin D system in brain function.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20571365 DOI: 10.1097/FBP.0b013e32833c850f
Source DB: PubMed Journal: Behav Pharmacol ISSN: 0955-8810 Impact factor: 2.293